KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Astrana Health (ASTH) Depreciation & Amortization (IS) (2016 - 2025)

Astrana Health (ASTH) has disclosed Depreciation & Amortization (IS) for 13 consecutive years, with $16.4 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (IS) rose 193.71% to $16.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45.7 million through Dec 2025, up 1889.09% year-over-year, with the annual reading at $45.7 million for FY2025, 1889.09% up from the prior year.
  • Depreciation & Amortization (IS) hit $16.4 million in Q4 2025 for Astrana Health, up from $15.6 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $16.4 million in Q4 2025 to a low of -$17.5 million in Q4 2024.
  • Historically, Depreciation & Amortization (IS) has averaged $4.4 million across 5 years, with a median of $4.5 million in 2021.
  • Biggest five-year swings in Depreciation & Amortization (IS): tumbled 457.02% in 2024 and later soared 193.71% in 2025.
  • Year by year, Depreciation & Amortization (IS) stood at $4.4 million in 2021, then tumbled by 321.67% to -$9.8 million in 2022, then surged by 150.12% to $4.9 million in 2023, then crashed by 457.02% to -$17.5 million in 2024, then skyrocketed by 193.71% to $16.4 million in 2025.
  • Business Quant data shows Depreciation & Amortization (IS) for ASTH at $16.4 million in Q4 2025, $15.6 million in Q3 2025, and $6.9 million in Q2 2025.